ARCHIVES

Albino African Skin Cancer Study To Be Reevaluated

This article is from The Cancer Letter archive.

Vol. 06 No. 15 | April 11, 1980

Download PDF Visit The Full Archive

Related Articles

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

February 24, 1995

Working Group Nears Agreement On New Core Grant Guidelines

January 16, 1981

Combination of Pill, Pap Test, May Result In False Positive

February 27, 2004

In Brief: Anderson Assumes ACCC President, Enck President Elect; Reagan Reappoints Montgomery

April 11, 1986

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011